Examination Report |
1 | Order | 07 Aug 2008 |
1 | TM-1 | 07 Aug 2008 |
10 | Journal Copy | 25 Feb 2015 |
11 | O-3 Notice | 28 Nov 2017 |
12 | TM-R(RENEWAL OF TRADE MARK) | 07 Aug 2018 |
13 | Power of Attorney | |
2 | Additional Representation Sheet | 07 Aug 2008 |
2 | TM-1 | 07 Aug 2008 |
3 | Additional Representation Sheet | 07 Aug 2008 |
3 | Examination Report | 07 Aug 2008 |
4 | Examination Report | 07 Aug 2008 |
4 | Order | 07 Aug 2008 |
5 | Reply to Exam Report (MIS-R) | 23 May 2009 |
6 | Note Sheet | 18 Jan 2013 |
7 | Hearing Notice | 18 Jan 2013 |
8 | Power of Attorney | 05 Feb 2013 |
8 | TM-16 | 05 Feb 2013 |
9 | Power of Attorney | 05 Feb 2013 |
9 | TM-16 | 05 Feb 2013 |
1 | O3 NOTICE | 5450888 | 24 Nov 2017 | |
2 | RENEWAL INTIMATION LETTER | 6821639 | 11 Aug 2018 |
The application for Doxa-dura was made on 07 August 2008.
The trademark applicant for Doxa-dura is AUROBINDO PHARMA.
Doxa-dura is applied in class(es) 5.
Application for Doxa-dura is on Registered stage.
Application Id allotted to Doxa-dura is 1718937.
Trademark agent or attorney for the application is Daswani & Daswani.
Doxa-dura filed with the Intellectual property office as a WORD.